Jean-Pierre Sommadossi, Atea CEO

Roche-Atea’s Covid-19 pill fails mid-stage tri­al, cloud­ing fu­ture for close­ly watched pro­gram

When Mer­ck an­nounced this month that its Covid-19 pill cut new­ly di­ag­nosed pa­tients’ risk of be­ing hos­pi­tal­ized by 50%, re­searchers and an­a­lysts hoped that …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.